Litigation

• 3^rd Circ. Doubts Jurisdiction In Generic-Fosamax Appeal (subscription required)
• Mirena IUD Lawsuit Discovery Continues in New Jersey and MDL
• Abbott Ordered to Produce “Overdue” Docs in Depakote Lawsuits
• J&J Fights Attys’ Pursuit of Confidential Risperdal Docs (subscription required)
• Pain-Pump Seller SJO Lied to Get $10M Policy, Insurer Says (subscription required)
• Stryker Inks 1^st Settlements in NJ Hip Implant Suits (subscription required)
• Eli Lilly Defeats Soldier’s Cymbalta “Brain Zap” Suit (subscription required)
• 4^th Circ. Questions Basis for Generic-Drug Injury Appeal (subscription required)
• Stryker Hip Implant Suit Stays in Federal MDL (subscription required)
• Pa. High Court Jettisons Wyeth’s $9M Prempro Appeal (subscription required)
• AMS Mesh Lawsuits Set for First Two Bellwether Trials in MDL
• 3^rd Circ. Asked to Tackle Venue Dispute in Paxil Suit (subscription required)
• Lipitor Suit Alleges Type 2 Diabetes Diagnosis Could Have Been Avoided
• 4^th Circ. Revives Purdue Pharma OxyContin FCA Row (subscription required)
• Neomedic Needleless Sling Lawsuit Consolidation Sought for 7^th MDL
• Wright Profemur Hip Settlement Reached to Avoid Trial
• Da Vinci Robotic Surgery Malpractice Lawsuits Results in $100k Verdict

Regulatory

• FDA and European Medicines Agency Launch Generic Drug Application Inspections Initiative
• FDA Issues Proposed Rule to Determine Safety and Effectiveness of Antibacterial Soaps
• AGs Urge FDA to Rethink High-Powered Painkiller Approval (subscription required)
• FDA Pushes Medical Device Self-Audit Pilot Program (subscription required)

Recalls

• Soliris (Eculizumab) Concentrated Solution for Intravenous Infusion by Alexion: Recall for Visible Particles

For a look at last week’s life science headlines, click here.